Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity.

Voriconazole in clinical practice.

Mikulska M
Novelli A
Aversa F
de Rosa FG
Girmenia C
Micozzi A
Sanguinetti M
Viscoli C.
CESARO, SIMONE

January 2012

Invasive fungal diseases are associated with significant morbidity and mortality in immunocompromize...

Voriconazole in clinical practice

Mikulska, Malgorzata Karolina
Novelli, A
Aversa, F
Cesaro, S
De Rosa, Fg
Girmenia, C
Micozzi, A
Sanguinetti, Maurizio (ORCID:0000-0002-9780-7059)
Viscoli, C.

January 2012

Invasive fungal diseases are associated with significant morbidity and mortality in immunocompromize...

Research Article Design and Evaluation of Voriconazole Eye Drops for the Treatment of Fungal Keratitis

Sakshi Malhotra
Anubha Khare
Kanchan Grover
Inderbir Singh
Pravin Pawar

August 2016

Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity.

Donnelly, J.P.
Pauw, B.E. de

January 2004

Voriconazole is a new antifungal agent that can be given orally and intravenously. It has proven eff...

[New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin]

Wout, J.W. van 't
Kuijper, E.J.
Verweij, P.E.
Kullberg, B.J.

January 2004

Contains fulltext : 58922.pdf (publisher's version ) (Closed access)The azole anti...

Louis D. Saravolatz, Section Editor Voriconazole: A New Triazole Antifungal Agent

Leonard B. Johnson
Carol A. Kauffman

January 2015

Voriconazole is a second-generation azole antifungal agent that shows excellent in vitro activity ag...

Voriconazole—a new therapeutic agent with an extended spectrum of antifungal activity

Donnelly, J.P.
De Pauw, B.E.

December 2004

AbstractVoriconazole is a new antifungal agent that can be given orally and intravenously. It has pr...

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

Herbrecht, R.
Denning, D.W.
Patterson, T.F.
Bennett, J.E.
Greene, R.E.
Oestmann, J.W.
Kern, W.V.
Marr, K.A.
Ribaud, P.
Lortholary, O.
Sylvester, R.J.
Rubin, R.H.
Wingard, J.R.
Stark, P.
Durand, C.
Caillot, D.
Chandrasekar, P.H.
Thiel, E. van
Hodges, M.R.
Schlamm, H.T.
Troke, P.F.
Pauw, B.E. de

January 2002

Contains fulltext : 185528.pdf (publisher's version ) (Open Access)BACKGROUND: Vor...

Update on the optimal use of voriconazole for invasive fungal infections

Asma Lat George R Thompson III

February 2011

Asma Lat1 George R Thompson III21Department of Pharmacy, New York-Presbyterian Hospital, Columbia Un...

Pharmacoeconomics of voriconazole in the management of invasive fungal infections

Al-Badriyeh, D.
Heng, S.C.
Neoh, C.F.
Slavin, M.
Stewart, K.
Kong, D.C.M.

January 2010

The incidence of invasive fungal infection has risen in recent years with the introduction of more i...

Voriconazole-Susceptible and Voriconazole-Resistant Aspergillus fumigatus Coinfection

Kolwijck, E.
Hoeven, H. van der
Sevaux, R.G.L. de
Oever, J. ten
Rijstenberg, L.L.
Lee, H.A.L. van der
Zoll, J.
Melchers, W.J.G.
Verweij, P.E.

January 2016

Contains fulltext : 166535.pdf (publisher's version ) (Closed access

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Maertens, Johan
Raad, Issam I
Marr, Kieren A
Patterson, Thomas F
Kontoyiannis, Dimitrios P
Cornely, Oliver A
Bow, Eric J
Rahav, Galia
Neofytos, Dionysios
Aoun, Mickael
Baddley, John W
Giladi, Michael
Heinz, Werner J
Herbrecht, Raoul
Hope, William
Karthaus, Meinolf
Lee, Dong-Gun
Lortholary, Olivier
Morrison, Vicki A
Oren, Ilana
Selleslag, Dominik
Shoham, Shmuel
Thompson, George R
Lee, Misun
Maher, Rochelle M
Schmitt-Hoffmann, Anne-Hortense
Zeiher, Bernhardt
Ullmann, Andrew J

February 2016

Isavuconazole is a novel triazole with broad-spectrum antifungal activity. The SECURE trial assessed...

Voriconazole: A new triazole antifungal

Janelle A Sabo
Susan M Abdel-rahman

September 2016

www.theannals.com Until the 1940s, relatively few agents were available forthe treatment of systemic...

Voriconazole: A New Triazole Antifungal

Janelle A Sabo
Susan M Abdel-rahman

December 2014

www.theannals.com Until the 1940s, relatively few agents were available forthe treatment of systemic...

Voriconazole salvage treatment of invasive candidiasis.

Ostrosky-Zeichner, L.
Oude Lashof, A.M.L.
Kullberg, B.J.
Rex, J.H.

January 2003

Item does not contain fulltextData on the salvage treatment of invasive candidiasis with voriconazol...

Voriconazole in clinical practice.

Mikulska M
Novelli A
Aversa F
de Rosa FG
Girmenia C
Micozzi A
Sanguinetti M
Viscoli C.
CESARO, SIMONE

January 2012

Invasive fungal diseases are associated with significant morbidity and mortality in immunocompromize...

Voriconazole in clinical practice

Mikulska, Malgorzata Karolina
Novelli, A
Aversa, F
Cesaro, S
De Rosa, Fg
Girmenia, C
Micozzi, A
Sanguinetti, Maurizio (ORCID:0000-0002-9780-7059)
Viscoli, C.

January 2012

Invasive fungal diseases are associated with significant morbidity and mortality in immunocompromize...

Research Article Design and Evaluation of Voriconazole Eye Drops for the Treatment of Fungal Keratitis

Sakshi Malhotra
Anubha Khare
Kanchan Grover
Inderbir Singh
Pravin Pawar

August 2016

Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity.

Donnelly, J.P.
Pauw, B.E. de

January 2004

Voriconazole is a new antifungal agent that can be given orally and intravenously. It has proven eff...

[New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin]

Wout, J.W. van 't
Kuijper, E.J.
Verweij, P.E.
Kullberg, B.J.

January 2004

Contains fulltext : 58922.pdf (publisher's version ) (Closed access)The azole anti...

Louis D. Saravolatz, Section Editor Voriconazole: A New Triazole Antifungal Agent

Leonard B. Johnson
Carol A. Kauffman

January 2015

Voriconazole is a second-generation azole antifungal agent that shows excellent in vitro activity ag...

Voriconazole—a new therapeutic agent with an extended spectrum of antifungal activity

Donnelly, J.P.
De Pauw, B.E.

December 2004

AbstractVoriconazole is a new antifungal agent that can be given orally and intravenously. It has pr...

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

Herbrecht, R.
Denning, D.W.
Patterson, T.F.
Bennett, J.E.
Greene, R.E.
Oestmann, J.W.
Kern, W.V.
Marr, K.A.
Ribaud, P.
Lortholary, O.
Sylvester, R.J.
Rubin, R.H.
Wingard, J.R.
Stark, P.
Durand, C.
Caillot, D.
Chandrasekar, P.H.
Thiel, E. van
Hodges, M.R.
Schlamm, H.T.
Troke, P.F.
Pauw, B.E. de

January 2002

Contains fulltext : 185528.pdf (publisher's version ) (Open Access)BACKGROUND: Vor...

Update on the optimal use of voriconazole for invasive fungal infections

Asma Lat George R Thompson III

February 2011

Asma Lat1 George R Thompson III21Department of Pharmacy, New York-Presbyterian Hospital, Columbia Un...

Pharmacoeconomics of voriconazole in the management of invasive fungal infections

Al-Badriyeh, D.
Heng, S.C.
Neoh, C.F.
Slavin, M.
Stewart, K.
Kong, D.C.M.

January 2010

The incidence of invasive fungal infection has risen in recent years with the introduction of more i...

Voriconazole-Susceptible and Voriconazole-Resistant Aspergillus fumigatus Coinfection

Kolwijck, E.
Hoeven, H. van der
Sevaux, R.G.L. de
Oever, J. ten
Rijstenberg, L.L.
Lee, H.A.L. van der
Zoll, J.
Melchers, W.J.G.
Verweij, P.E.

January 2016

Contains fulltext : 166535.pdf (publisher's version ) (Closed access

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Maertens, Johan
Raad, Issam I
Marr, Kieren A
Patterson, Thomas F
Kontoyiannis, Dimitrios P
Cornely, Oliver A
Bow, Eric J
Rahav, Galia
Neofytos, Dionysios
Aoun, Mickael
Baddley, John W
Giladi, Michael
Heinz, Werner J
Herbrecht, Raoul
Hope, William
Karthaus, Meinolf
Lee, Dong-Gun
Lortholary, Olivier
Morrison, Vicki A
Oren, Ilana
Selleslag, Dominik
Shoham, Shmuel
Thompson, George R
Lee, Misun
Maher, Rochelle M
Schmitt-Hoffmann, Anne-Hortense
Zeiher, Bernhardt
Ullmann, Andrew J

February 2016

Isavuconazole is a novel triazole with broad-spectrum antifungal activity. The SECURE trial assessed...

Voriconazole: A new triazole antifungal

Janelle A Sabo
Susan M Abdel-rahman

September 2016

www.theannals.com Until the 1940s, relatively few agents were available forthe treatment of systemic...

Voriconazole: A New Triazole Antifungal

Janelle A Sabo
Susan M Abdel-rahman

December 2014

www.theannals.com Until the 1940s, relatively few agents were available forthe treatment of systemic...

Voriconazole salvage treatment of invasive candidiasis.

Ostrosky-Zeichner, L.
Oude Lashof, A.M.L.
Kullberg, B.J.
Rex, J.H.

January 2003

Item does not contain fulltextData on the salvage treatment of invasive candidiasis with voriconazol...

Voriconazole in clinical practice.

Mikulska M
Novelli A
Aversa F
de Rosa FG
Girmenia C
Micozzi A
Sanguinetti M
Viscoli C.
CESARO, SIMONE

January 2012

Invasive fungal diseases are associated with significant morbidity and mortality in immunocompromize...

Voriconazole in clinical practice

Mikulska, Malgorzata Karolina
Novelli, A
Aversa, F
Cesaro, S
De Rosa, Fg
Girmenia, C
Micozzi, A
Sanguinetti, Maurizio (ORCID:0000-0002-9780-7059)
Viscoli, C.

January 2012

Invasive fungal diseases are associated with significant morbidity and mortality in immunocompromize...

Research Article Design and Evaluation of Voriconazole Eye Drops for the Treatment of Fungal Keratitis

Sakshi Malhotra
Anubha Khare
Kanchan Grover
Inderbir Singh
Pravin Pawar

August 2016

Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity.

Abstract

Extracted data

Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity.

Abstract

Extracted data

Related items

Related items